Global High Potency Active Pharmaceutical Ingredients (HPAPI) market is poised to grow at a high CAGR of 9% in the next 5 years.
Rising incidence of cancer and other chronic diseases, increasing R&D activities & investments, advancements in oncology therapies, growing demand for targeted therapies, advances in manufacturing technologies, innovation and pipeline expansion, and increasing outsourcing to CDMOs are some of the key factors driving the HPAPI market. The market is marked by the presence of key players […]
Continue Reading